Menu

Blog

Sep 2, 2023

Innovative insights into effects of hematopoietic changes on colon cancer, unveiling therapeutic avenues

Posted by in categories: biotech/medical, genetics

In a recent study published in the Journal of Experimental Medicine, researchers investigated whether bone marrow-derived cells with heterozygous loss of Dnmt3a (Dnmt3a+/Δ), the most common genetic alteration in clonal hematopoiesis (CH), contribute to colitis-associated colon cancer (CAC) pathogenesis.

Study: Hematopoietic-specific heterozygous loss of Dnmt3a exacerbates colitis-associated colon cancer. Image Credit: vetpathologist/Shutterstock.com.

Comments are closed.